The increasing phenomenon of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a major problem to global public health and law enforcement. These chemicals, frequently synthesized to circumvent existing drug laws, rapidly appear on the market and are marketed as "legal highs" or "research chemicals," attracting individual